The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identification of biomarkers to predict response to single-agent platinum chemotherapy in metastatic triple-negative breast cancer (mTNBC): Correlative studies from TBCRC009.
Steven J. Isakoff
No relevant relationships to disclose
Lei He
No relevant relationships to disclose
Erica L. Mayer
No relevant relationships to disclose
Paul E. Goss
No relevant relationships to disclose
Tiffany A. Traina
No relevant relationships to disclose
Lisa A. Carey
No relevant relationships to disclose
Karen Krag
No relevant relationships to disclose
Minetta C. Liu
No relevant relationships to disclose
Hope S. Rugo
No relevant relationships to disclose
Vered Stearns
No relevant relationships to disclose
Steven E. Come
No relevant relationships to disclose
Paula D. Ryan
No relevant relationships to disclose
Dianne M. Finkelstein
No relevant relationships to disclose
Anne-Renee Hartman
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Judy Ellen Garber
No relevant relationships to disclose
Kirsten Timms
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Eric P. Winer
No relevant relationships to disclose
Leif W. Ellisen
No relevant relationships to disclose